Contributed to SeNaTe (7nm technology), TAPES3 (3nm semiconductor pilotline), and ADALAM (laser micromachining for zero-failure manufacturing).
DEMCON PRODUCTION BV
Dutch high-tech contract manufacturer specializing in precision production of semiconductor equipment, medical devices, and safety-critical systems.
Their core work
DEMCON Production BV is the manufacturing and production arm of the DEMCON group, a Dutch high-tech systems company based in Enschede. They specialize in contract manufacturing of precision instruments, medical devices, and semiconductor equipment — turning advanced prototypes into reliable production-grade systems. In H2020 projects, they consistently appear as a third-party contributor, providing production expertise and manufacturing capability to consortia working on everything from laser micromachining to autonomous drones and pandemic-response medical equipment.
What they specialise in
Involved in MDOT (Medical Device Obligations Taskforce covering MDR, biocompatibility, testing) and CO-VERSATILE (rapid production adaptation for medical supplies during pandemics).
Across ADALAM, SeNaTe, TAPES3, and COMP4DRONES, they provide production-level manufacturing for precision mechatronic systems.
Third-party contributor to AIMS-2-TRIALS, a major autism biomarker and clinical outcomes study, likely providing instrumentation or measurement devices.
Contributed to COMP4DRONES, a framework project for safe and autonomous drone applications.
How they've shifted over time
In the early period (2015–2018), DEMCON Production focused on precision manufacturing for semiconductor and advanced materials sectors, contributing to laser micromachining (ADALAM) and next-generation chip fabrication (SeNaTe). From 2018 onward, their portfolio diversified significantly into medical devices, regulatory compliance (MDOT), autonomous drones (COMP4DRONES), and rapid pandemic manufacturing response (CO-VERSATILE). This shift signals a deliberate move from pure semiconductor production toward broader high-tech manufacturing, especially in regulated sectors like health and safety-critical systems.
DEMCON Production is expanding from semiconductor equipment into regulated medical device manufacturing and rapid-response production, positioning them as a go-to partner for projects needing compliant, high-quality production of safety-critical technology.
How they like to work
DEMCON Production operates exclusively as a third-party contributor across all seven H2020 projects — they are brought in by consortium members (likely the parent DEMCON group or close partners) to provide specialized manufacturing and production capabilities. Despite this indirect role, they have touched 224 unique partners across 21 countries, indicating that their production expertise is valued across a wide range of European consortia. Working with them means accessing a reliable production partner who delivers manufacturing capability without seeking project leadership.
Through their third-party contributions, DEMCON Production has been embedded in consortia involving 224 unique partners across 21 countries, giving them an unusually broad network for a production-focused company. Their connections span semiconductor, health, and digital sectors across most of Western and Central Europe.
What sets them apart
DEMCON Production occupies a rare niche: a high-tech contract manufacturer that operates at the intersection of semiconductor fabrication, medical devices, and autonomous systems — all sectors where production quality and regulatory compliance are non-negotiable. Unlike generic manufacturing partners, they bring deep experience with precision mechatronic systems and have demonstrated the ability to pivot quickly, as shown by their pandemic-era medical supply production work. For consortium builders, they solve the persistent problem of bridging the gap between a research prototype and a reliable, compliant product.
Highlights from their portfolio
- CO-VERSATILEDemonstrates rapid manufacturing adaptation for pandemic response — producing medical supplies and equipment under extreme time pressure, showcasing production agility.
- AIMS-2-TRIALSLargest project by duration (2018–2026), a major IMI-style autism research initiative where DEMCON Production likely provides specialized measurement or diagnostic instrumentation.
- MDOTDirectly addresses Medical Device Regulation (MDR) compliance including biocompatibility testing and blockchain-based traceability — positions them at the heart of EU medical device manufacturing requirements.